NASDAQ:MRAI Marpai (MRAI) Stock Price, News & Analysis $2.20 +0.04 (+1.85%) As of 08/7/2026 03:55 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock About Marpai Stock (NASDAQ:MRAI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Marpai alerts:Sign Up Key Stats Today's Range$2.16▼$2.2450-Day Range$0.50▼$2.3752-Week Range$0.22▼$2.50Volume34,130 shsAverage Volume70,214 shsMarket Capitalization$59.12 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Marpai Inc. is a technology-driven healthcare benefits management company that leverages data analytics and artificial intelligence to optimize health outcomes and control costs for self-insured employers. Its flagship Marpai Health Platform integrates personalized care pathways, advanced member engagement tools and real-time claims analytics. By combining machine learning models with clinical expertise, Marpai identifies risk patterns early and guides members toward cost-effective, high-quality care. Marpai’s suite of services encompasses underwriting, care coordination, pharmacy benefits management and virtual health coaching, all delivered through a unified digital interface. The platform offers proactive notifications, personalized recommendations and continuous support to help members navigate complex healthcare decisions. Employers using Marpai’s solutions gain greater visibility into cost drivers and can realize measurable reductions in total medical expenses. Founded by a team of healthcare and technology professionals, Marpai is headquartered in the United States and primarily serves mid-sized to large self-insured organizations across diverse industries. The company’s data-driven approach underpins sustainable cost management and enhances member satisfaction through transparent pricing, targeted interventions and evidence-based care pathways. Marpai began trading on the NASDAQ under the symbol MRAI, marking its transition to a public company committed to advancing innovation in digital health. While focused on the U.S. market, Marpai continues to explore strategic partnerships and product enhancements designed to expand its capabilities and refine its precision health insights.AI Generated. May Contain Errors. Read More Receive MRAI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Marpai and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MRAI Stock News HeadlinesMarpai Announces $12 Million Private Placement led by Mitchell CompaniesJuly 29, 2026 | prnewswire.comMarpai Inc. Announces Debt Restructuring Agreements with JGB Capital and AXA, Reducing Debt Service by $26.4 Million Through 2027 and Enhances Near term LiquidityJuly 20, 2026 | prnewswire.comThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.August 8 at 1:00 AM | Porter & Company (Ad)BestGrowthStocks.Com Issues Comprehensive Analysis of Marpai IncJuly 12, 2026 | stockhouse.comMarpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA ...May 27, 2026 | tmcnet.comMarpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026May 26, 2026 | prnewswire.comMARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTSMay 15, 2026 | prnewswire.comMarpai, Inc. Announces Significant New Business Wins across TPA and MarpaiRx; Solidifies Forecast for ProfitabilityMay 11, 2026 | prnewswire.comSee More Headlines MRAI Stock Analysis - Frequently Asked Questions How have MRAI shares performed this year? Marpai's stock was trading at $0.6310 at the beginning of 2026. Since then, MRAI shares have increased by 248.7% and is now trading at $2.20. How were Marpai's earnings last quarter? Marpai, Inc. (NASDAQ:MRAI) issued its earnings results on Thursday, May, 9th. The company reported ($0.46) earnings per share for the quarter. The company had revenue of $7.39 million for the quarter. When did Marpai's stock split? Marpai shares reverse split on Thursday, June 29th 2023.The 1-4 reverse split was announced on Thursday, June 29th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 29th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. When did Marpai IPO? Marpai (MRAI) raised $25 million in an IPO on Wednesday, October 27th 2021. The company issued 6,300,000 shares at $4.00 per share. ThinkEquity acted as the underwriter for the IPO. How do I buy shares of Marpai? Shares of MRAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Marpai own? Based on aggregate information from My MarketBeat watchlists, some other companies that Marpai investors own include NVIDIA (NVDA), Meta Platforms (META), Snowflake (SNOW), iShares Core S&P 500 ETF (IVV), Tesla (TSLA), Airbnb (ABNB) and Allegion (ALLE). Company Calendar Last Earnings5/09/2024Today8/08/2026Next Earnings (Estimated)8/12/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryN/A Current SymbolNASDAQ:MRAI CIK1844392 Webwww.marpaihealth.com Phone646-303-3483FaxN/AEmployees150Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.87) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$28.75 million Net Margins-85.70% Pretax Margin-86.66% Return on EquityN/A Return on Assets-100.23% Debt Debt-to-Equity RatioN/A Current Ratio0.82 Quick Ratio0.82 Sales & Book Value Annual Sales$34.87 million Price / Sales1.70 Cash FlowN/A Price / Cash FlowN/A Book Value($1.72) per share Price / Book-1.28Miscellaneous Outstanding Shares26,872,000Free Float5,605,000Market Cap$59.12 million OptionableNo Data Beta4.74 The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:MRAI) was last updated on 8/8/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredSpaceX Earnings Crash: The End of the AI Bubble?Jeremy Grantham calls today's market the biggest investment bubble in American history, and Ray Dalio agrees. ...TradeSmith | SponsoredSpaceX pays a 10X launch penaltySpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...Freedom Financial | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredWho buys 200 tonnes of mercury a year?Bolivia, a landlocked nation of 12 million, imports roughly 200 tonnes of mercury a year, more than China, Ind...Behind the Markets | SponsoredWhat to do if you missed out on SpaceXJason Bodner spent two decades placing massive trades for Wall Street's biggest funds. He built a tool that fl...Brownstone Research | SponsoredMy latest trade blew past my target by 6xTim Sykes set a target of 10 to 20 percent on a recent trade. It closed at 121 percent, six times his original...Tim Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marpai, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marpai With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
